Clinical trial
The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma
NCT03154892 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Xi'an Jiaotong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma
- Lead sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 1, 2017
- Completion date
- December 31, 2017
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neovascular glaucoma